ASX Announcements


 
    Investor Presentation  
 
    Investor Presentation  
 
    Quarterly Activities Report & Appendix 4C  
 
    Quarterly Activities Report & Appendix 4C  
 
    Presentation at South-West Connect ASX Showcase  
 
    Letter to Shareholders regarding Annual General Meeting  
 
    Notice of Annual General Meeting  
 
    Annual Report to shareholders  
 
    Appendix 4G and Corporate Governance Statement  
 
    Change of Director's Interest Notice x 2  
 
    LGP expands into Psychedelic Medicines  
 
    First Danish Shipment to Australia, Key Appointments  
 
    AGM Date and Closing Date for Director Nominations  
 
    Notification regarding unquoted securities - LGP  
 
    Preliminary Final Report  
 
    Preliminary Final Report  
 
    Change of Director's Interest Notice x 2  
 
    Cleansing Notice  
 
    Application for quotation of securities - LGP  
 
    Notification regarding unquoted securities - LGP  
 
    Application for quotation of securities - LGP  
 
    Notification regarding unquoted securities - LGP  
 
    Quarterly Activities Report & Appendix 4C  
 
    Results of Meeting  
 
    Change in substantial holding  
 
    Becoming a substantial holder  
 
    Investor Webinar - Denmark Acquisition  
 
    Change in substantial holding  
 
    Change in substantial holding - Tiga Trading Pty Ltd  
 
    Becoming a substantial holder  
 
    Cleansing Notice  
 
    Investor Presentation  
 
    Application for quotation of securities - LGP  
 
    Proposed issue of securities - LGP  
 
    Investor Presentation - Denmark acquisition & capital raise  
 
    LGP acquires Denmark facility and undertakes share placement  
 
    Trading Halt  
 
    Exclusive distribution partner - leading Polish pharma group  
 
    Letter to Shareholders regarding General Meeting  
 
    Notice of General Meeting  
 
    Update to Sales and Distribution in Australia and Germany  
 
    Becoming a substantial holder - Tiga Trading Pty Ltd  
 
    Results of Meeting  
 
    $2.5m firm order increases expected DEMECAN revenue to $5.7m  
 
    Quarterly Activities Report & Appendix 4C  
 
    Letter to Shareholders regarding General Meeting  
 
    Notice of Extraordinary General Meeting  
 
    LGP agrees Danish Distribution Agreement with Balancial  
 
    Ceasing to be a substantial holder  
 
    Proposed issue of Securities - LGP  
 
    Firm purchase order from Demecan and acquisition of land  
 
    Change of Director's Interest Notice x 4  
 
    Appendix 3G - employee share rights  
 
    Cleansing Notice  
 
    Appendix 2A - incentive shares & conversion of share rights  
 
    Appendix 2A - shares for services  
 
    Appendix 2A - conversion of Performance Rights  
 
    Appendix 2A - Share Purchase Plan shares  
 
    LGP delivers first French shipment  
 
    LGP Completes Successful $5 Million SPP  
 
    LGP Completes Successful $5 Million SPP  
 
    Change in substantial holding  
 
    Change in substantial holding  
 
    Company Update and Presentation of Half Yearly Results  
 
    Half Yearly Report and Accounts  
 
    Half Yearly Report and Accounts  
 
    Large Scale Cannabis Study Launched  
 
    Large Scale Cannabis Study Launched  
 
    Appendix 2A - issue of placement shares & cleansing notice  
 
    Share Purchase Plan Offer Booklet  
 
    Cleansing Notice  
 
    Proposed issue of Securities - LGP  
 
    LGP secures firm commitments to raise $22 million  
 
    Appendix 2A  
 
    Appendix 2A - exercise of options  
 
    Appendix 2A - release of shares from escrow  
 
    LGP exports first commercial shipment to Germany  
 
    Trading Halt  
 
    Quarterly Activities Report & Appendix 4C  
 
    Notice of release from escrow  
 
    LGP wins French government tender  
 
    Appendix 2A - options exercise & cleansing notice  
 
    Change of Director's interest notice x 4  
 
    Appendix 2A - options exercise & cleansing notice  
 
    Appendix 2A  
 
    Appendix 3G  
 
    Issue of securities approved at AGM  
 
    TGA announces final CBD down-scheduling decision  
 
    Results of Annual General Meeting  
 
    Company Update to the AGM  
 
    First Australian Medicinal Cannabis Oils Exported to Germany  
 
    Proposed issue of Securities - LGP  
 
    LGP enters strategic partnership with HIF  
 
    Trading Halt  
 
    Proposed issue of Securities - LGP  
 
    Letter to Shareholders regarding Annual General Meeting  
 
    Notice of Annual General Meeting  
 
    Appendix 2A - Exercise of Options and Cleansing Notice  
 
    Quarterly Activities Report & Appendix 4C  
 
    Becoming a substantial holder- Tiga Trading Pty Ltd  
 
    Little Green Pharma granted GMP Licence  
 
    Appendix 2A - Release from Escrow  
 
    AGM Date and Closing Date for Director Nominations  
 
    Notice of release from escrow  
 
    TGA Medicinal Cannabis Post Market Survey  
 
    LGP welcomes proposed CBD down-scheduling  
 
    Change in substantial holding  
 
    Appendix 4G  
 
    2020_Annual Report to shareholders  
 
    Appendix 2A and Cleansing Notice  
 
    Proposed issue of Securities - LGP  
 
    Appendix 2A and Cleansing Notice  
 
    Appendix 2A - Exercise of Options and Cleansing Notice  
 
    Appendix 2A - Release from Escrow  
 
    Change in substantial holding  
 
    Notice of Release from Escrow  
 
    Investor Update Webinar  
 
    Investor Presentation  
 
    July 2020_Quarterly Activities Report and Appendix 4C  
 
    Medicinal Cannabis Permit Granted for Expanded Facility  
 
    Appendix 2A - Exercise of Options and Cleansing Notice  
 
    Appendix 2A - Release from Escrow  
 
    Notice of Release from Escrow  
 
    Change of Company Secretary  
 
    Strategic Shipment Exported to the UK  
 
    Sales Update - April 2020  
 
    Clarification Statement  
 
    ODC Manufacturing Permit Granted  
 
    Proposed issue of Securities - LGP  
 
    Investor Presentation  
 
    March 2020_Quarterly Activities Report and Appendix 4C  
 
    Virtual Conference  
 
    First UK Shipment of Australian Medicinal Cannabis Oil  
 
    COVID-19 Business Update  
 
    Commissioning of Cultivation Facility Expansion Complete  
 
    Investor Presentation  
 
    Expanded Medicinal Licence and new Manufacturing Licence  
 
    Fourth Medicinal Cannabis Oil Product  
 
    Appendix 4D and Half Yearly Report  
 
    German Purchase Agreement with Demecan  
 
    Becoming a substantial holder - Elixxer Ltd  
 
    Becoming a substantial holder - FS  
 
    Initial Director's Interest Notice - AC  
 
    Initial Director's Interest Notice - FS  
 
    Initial Director's Interest Notice - NF  
 
    Initial Director's Interest Notice - MLB  
 
    Binding Purchase Agreement with UK-Based Astral Health  
 
    Confirmation Statements  
 
    Top 20 Holders  
 
    Distribution Schedule  
 
    Securities Trading Policy  
 
    Corporate Governance Statement  
 
    Employee Incentive Plan Terms  
 
    Updated Pro-Forma Balance Sheet  
 
    Financial Statements - 30 June 2019  
 
    Financial Statements - 30 June 2018  
 
    Constitution  
 
    Supplementary Prospectus  
 
    Prospectus  
 
    Appendix 1A and Information Form and Checklist  
 
    ASX Notice - Admission to Official List